XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,851,000 $ 962,000
Accounts receivable, net of allowance 1,064,000 513,000
Inventories, net of allowance 120,000 241,000
Prepaid expenses and other current assets 118,000 85,000
Total current assets 3,153,000 1,801,000
Equipment, net of depreciation 287,000 61,000
Other non-current assets 124,000 69,000
Investment in South Korean joint venture 33,000 48,000
Right of use, operating lease, net of amortization 867,000 453,000
Clyra Medical prepaid marketing (Note 10) 394,000 591,000
Total assets 4,858,000 3,023,000
Current liabilities:    
Accounts payable and accrued expenses 940,000 559,000
Debt obligations, net of discount (Note 4) 100,000 314,000
Deferred revenue 17,000 89,000
Lease liability 97,000 103,000
Deposits 184,000 79,000
Total current liabilities 1,576,000 1,374,000
Long-term liabilities:    
Debt obligations, net of current (Note 4) 237,000 180,000
Lease liability, net of current 773,000 349,000
Total long-term liabilities 1,271,000 716,000
Total liabilities 2,847,000 2,090,000
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS’ EQUITY (DEFICIT):    
Preferred Series A, $0.00067 Par Value, 50,000,000 Shares Authorized, -0- Shares Issued and Outstanding, at December 31, 2022 and December 31, 2021 0 0
Common stock, $0.00067 Par Value, 400,000,000 Shares Authorized, 278,462,706 and 255,893,726 Shares Issued, at December 31, 2022 and December 31, 2021 186,000 171,000
Additional paid-in capital 148,435,000 143,718,000
Accumulated deficit (143,594,000) (139,121,000)
Accumulated other comprehensive loss (149,000) (115,000)
Total BioLargo Inc. and subsidiaries stockholders’ equity 4,878,000 4,653,000
Non-controlling interest (Note 10) (2,867,000) (3,720,000)
Total stockholders’ equity 2,011,000 933,000
Total liabilities and stockholders’ equity 4,858,000 3,023,000
Entities, Excluding Partially Owned Subsidiary [Member]    
Current liabilities:    
Accounts payable and accrued expenses 940,000 559,000
Partially Owned Subsidiary [Member]    
Current liabilities:    
Accounts payable and accrued expenses 238,000 230,000
Long-term liabilities:    
Debt obligations, net of current (Note 4) $ 261,000 $ 187,000